Citation:Sprauten M, Brydøy M, Haugnes HS, Cvancarova M, Bjøro T, Bjerner J, et al 2014

From Cancer Guidelines Wiki

Citation


Sprauten M, Brydøy M, Haugnes HS, Cvancarova M, Bjøro T, Bjerner J, et al. Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors. J Clin Oncol 2014 Feb 20;32(6):571-8 Available from: http://www.ncbi.nlm.nih.gov/pubmed/24419125.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Testicular function after cancer treatmentDr Jessica Harriscompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:Is the testicular function of male cancer survivors who had cancer treatment, more adversely affected than males in the general population, as measured by markers of their testicular function after treatment?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Is the testicular function of male cancer survivors who had cancer treatment, more adversely affected than males in the general population, as measured by markers of their testicular function after treatment?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Testicular function